Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI‐SPA Replace Registry
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31662 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Julio Echarte-Morales und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Tricuspid Valve, Heart Valve Prosthesis Implantation, Cardiac Catheterization. Die Arbeit nennt 26 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Transcatheter tricuspid valve replacement (TTVR) is a novel technique for the treatment of symptomatic tricuspid regurgitation (TR).
Aims
This study aims to present the initial experience in Spain and report short‐term outcomes of this therapy.
Methods
This was a multicenter, retrospective registry including 48 patients who underwent percutaneous tricuspid valve replacement between April 2022 and September 2024. The primary efficacy objectives were procedural success and the degree of regurgitation at discharge. The primary safety objectives included all‐cause mortality, hospitalization for heart failure, and other major adverse cardiovascular events.
Results
A total of 48 patients were included (79 [72−82] years, 75% women, TRISCORE 5 [4−6] points). Sixty‐three percent of the patients were in New York Heart Association (NYHA) functional class ≥ III. TR was predominantly of secondary etiology (87%). Procedural success was 98%. The entire treated population achieved TR ≤ 2+ at discharge (100%), and TR ≤ 1+ was achieved in 94% of patients. A permanent pacemaker was implanted in 15.8% of patients. At 30 days, overall mortality was 2.2%, 82% of patients were in NYHA class I/II, and 100% and 94% had TR grades ≤ 2+ and ≤ 1+, respectively.
Conclusions
Percutaneous tricuspid valve replacement proved to be effective and safe, with a high procedural success rate and a low incidence of adverse events. At 30 days, a significant reduction in TR grade was observed, along with an improvement in functional class.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.
- Cardiovascular Research Group, Department of Cardiology, University Hospital Alvaro Cunqueiro, Fundación Biomédica Galicia Sur, Servizo Galego de Saude, University of Vigo, Vigo, Spain.
- Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
- Department of Cardiology, Cardiovascular Institute, Hospital Clínic, Barcelona, Spain.
- Department of Cardiology, Hospital Universitario de Salamanca, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
- Department of Cardiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
ORCID-Profile: Julio Echarte-Morales, Laura Sanchis, Chi Hion Li, Fabian Blanco
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Echarte-Morales, J., Barreiro-Pérez, M., Nombela-Franco, L., Freixa, X., Cruz-González, I., Sánchez-Recalde, Á., Arzamendi, D., Baz, J. A., Mon, M., Sanchis, L., Laffond, A. E., Rodríguez, L. M. D., Li, C. H., Jiménez, P., Altisent, O. A., Blanco, F., Fernández-Golfín, C., Menduiña, I., & Estévez-Loureiro, R. (2025). Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI‐SPA Replace Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31662
Vancouver
Echarte-Morales J, Barreiro-Pérez M, Nombela-Franco L, Freixa X, Cruz-González I, Sánchez-Recalde Á, et al. Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI‐SPA Replace Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31662
BibTeX
@article{EcharteMorales2025,
author = {Echarte-Morales, Julio and Barreiro-Pérez, Manuel and Nombela-Franco, Luis and Freixa, Xavier and Cruz-González, Ignacio and Sánchez-Recalde, Ángel and Arzamendi, Dabit and Baz, Jose Antonio and Mon, Matias and Sanchis, Laura and Laffond, Ana E and Rodríguez, Luis Manuel Domínguez and Li, Chi Hion and Jiménez, Pilar and Altisent, Omar Abdul-Jawad and Blanco, Fabian and Fernández-Golfín, Covadonga and Menduiña, Irene and Estévez-Loureiro, Rodrigo},
title = {Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI‐SPA Replace Registry},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31662}
}
EUVIMED